Menu
Back to Journals » Cancer Management and Research » Volume 10
RETRACTED ARTICLE: Overexpression of chloride channel-3 predicts unfavorable prognosis and promotes cellular invasion in gastric cancer
Authors Peng J , Chen W, Chen J , Yuan Y , Zhang J , He Y
Received 13 December 2017
Accepted for publication 14 March 2018
Published 14 May 2018 Volume 2018:10 Pages 1163—1175
DOI https://doi.org/10.2147/CMAR.S159790
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Leylah Drusbosky
This paper has been retracted.
Peng J, Chen W, Chen J, Yuan Y, Zhang J, He Y. Cancer Manag Res. 2018;10:1163-1175.
We, the Editor and Publisher of the journal Cancer Management and Research, have retracted the following article.
Following publication of the article, concerns were raised about the duplication of images from Figure 3 with images from an unrelated article. Specifically,
- Images for Figure 3C and 3D have been duplicated with images for Figure 2c, 2d and 2h from Cao Q, Liu F, Ji K, et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res. 2017;36:29. https://doi.org/10.1186/s13046-017-0499-z.
The authors responded to our queries but were unable to provide a satisfactory explanation for the duplicated images or provide satisfactory data for the study. As verifying the validity of published work is core to the integrity of the scholarly record, the Publisher and Editor requested to retract the article and the authors agree with this decision. The authors wish to apologize for any inconvenience caused to the journal and readers.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.